Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Amibegron> ?p ?o }
Showing triples 1 to 94 of
94
with 100 triples per page.
- Amibegron abstract "Amibegron (SR-58,611A) was a drug developed by Sanofi–Aventis (now Sanofi) which acts as a selective agonist for the β3 adrenergic receptor. It is the first orally active β3 agonist developed that is capable of entering the central nervous system, and has antidepressant and anxiolytic effects.On July 31, 2008, Sanofi-Aventis announced that it has decided to discontinue development of amibegron.".
- Amibegron atcPrefix "none".
- Amibegron casNumber "121524-09-2".
- Amibegron fdaUniiCode "PDQ3ME68U3".
- Amibegron iupacName "Ethyl ([(7S)-7-([(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]amino)-5,6,7,8-tetrahydronaphthalen-2-yl]oxy)acetate".
- Amibegron pubchem "3035442".
- Amibegron thumbnail Amibegron.svg?width=300.
- Amibegron wikiPageID "17847394".
- Amibegron wikiPageLength "3592".
- Amibegron wikiPageOutDegree "12".
- Amibegron wikiPageRevisionID "705623439".
- Amibegron wikiPageWikiLink Agonist.
- Amibegron wikiPageWikiLink Antidepressant.
- Amibegron wikiPageWikiLink Anxiolytic.
- Amibegron wikiPageWikiLink Beta-3_adrenergic_receptor.
- Amibegron wikiPageWikiLink Category:Abandoned_drugs.
- Amibegron wikiPageWikiLink Category:Alcohols.
- Amibegron wikiPageWikiLink Category:Beta-adrenergic_agonists.
- Amibegron wikiPageWikiLink Category:Chloroarenes.
- Amibegron wikiPageWikiLink Category:Phenol_ethers.
- Amibegron wikiPageWikiLink Category:Tetralins.
- Amibegron wikiPageWikiLink Central_nervous_system.
- Amibegron wikiPageWikiLink Sanofi.
- Amibegron wikiPageWikiLinkText "Amibegron".
- Amibegron wikiPageWikiLinkText "amibegron".
- Amibegron atcPrefix "none".
- Amibegron c "22".
- Amibegron casNumber "121524".
- Amibegron chembl "545437".
- Amibegron chemspiderid "108738".
- Amibegron cl "1".
- Amibegron h "26".
- Amibegron inchi "1".
- Amibegron inchikey "NQIZCDQCNYCVAS-RQBPZYBGBK".
- Amibegron iupacName "Ethyl acetate".
- Amibegron iupharLigand "568".
- Amibegron kegg "D08851".
- Amibegron legalStatus "Development terminated".
- Amibegron molecularWeight "403.898".
- Amibegron n "1".
- Amibegron o "4".
- Amibegron pubchem "3035442".
- Amibegron routesOfAdministration "Oral".
- Amibegron smiles "CCOCCOc3ccc1CCCNCCc2ccccc2".
- Amibegron stdinchi "1".
- Amibegron stdinchikey "NQIZCDQCNYCVAS-RQBPZYBGSA-N".
- Amibegron unii "PDQ3ME68U3".
- Amibegron verifiedrevid "437193151".
- Amibegron watchedfields "changed".
- Amibegron width "250".
- Amibegron wikiPageUsesTemplate Template:Adrenergics.
- Amibegron wikiPageUsesTemplate Template:Antidepressants.
- Amibegron wikiPageUsesTemplate Template:Anxiolytics.
- Amibegron wikiPageUsesTemplate Template:Chemspidercite.
- Amibegron wikiPageUsesTemplate Template:Drugbankcite.
- Amibegron wikiPageUsesTemplate Template:Drugbox.
- Amibegron wikiPageUsesTemplate Template:Ebicite.
- Amibegron wikiPageUsesTemplate Template:Fdacite.
- Amibegron wikiPageUsesTemplate Template:Keggcite.
- Amibegron wikiPageUsesTemplate Template:Nervous-system-drug-stub.
- Amibegron wikiPageUsesTemplate Template:Reflist.
- Amibegron wikiPageUsesTemplate Template:Stdinchicite.
- Amibegron subject Category:Abandoned_drugs.
- Amibegron subject Category:Alcohols.
- Amibegron subject Category:Beta-adrenergic_agonists.
- Amibegron subject Category:Chloroarenes.
- Amibegron subject Category:Phenol_ethers.
- Amibegron subject Category:Tetralins.
- Amibegron hypernym Drug.
- Amibegron type ChemicalSubstance.
- Amibegron type Drug.
- Amibegron type Agonist.
- Amibegron type Alcohol.
- Amibegron type Chemical.
- Amibegron type Drug.
- Amibegron type Ether.
- Amibegron type Hydrocarbon.
- Amibegron type Organohalide.
- Amibegron type Sympathomimetic.
- Amibegron type Organohalide.
- Amibegron type ChemicalObject.
- Amibegron type Thing.
- Amibegron type Q8386.
- Amibegron comment "Amibegron (SR-58,611A) was a drug developed by Sanofi–Aventis (now Sanofi) which acts as a selective agonist for the β3 adrenergic receptor. It is the first orally active β3 agonist developed that is capable of entering the central nervous system, and has antidepressant and anxiolytic effects.On July 31, 2008, Sanofi-Aventis announced that it has decided to discontinue development of amibegron.".
- Amibegron label "Amibegron".
- Amibegron sameAs Q4746121.
- Amibegron sameAs アミベグロン.
- Amibegron sameAs m.047bvx1.
- Amibegron sameAs Amibegron.
- Amibegron sameAs Amibegron.
- Amibegron sameAs Q4746121.
- Amibegron wasDerivedFrom Amibegron?oldid=705623439.
- Amibegron depiction Amibegron.svg.
- Amibegron isPrimaryTopicOf Amibegron.